Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T-cell lymphomas.
de Masson A, Guitera P, Brice P, Moulonguet I, Mouly F, Bouaziz JD, Battistella M, Madelaine I, Roux J, Ram-Wolff C, Cayuela JM, Bachelez H, Bensussan A, Michel L, Bagot M.
de Masson A, et al. Among authors: bachelez h.
Br J Dermatol. 2014 Mar;170(3):720-4. doi: 10.1111/bjd.12690.
Br J Dermatol. 2014.
PMID: 24438061